Sudafed and Bronchiectasis - a phase IV clinical study of FDA data

Summary:

Bronchiectasis is reported as a side effect among people who take Sudafed (pseudoephedrine hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for 1 - 2 years also take Mucinex, and have Primary immunodeficiency syndrome.

The phase IV clinical study analyzes which people have Bronchiectasis when taking Sudafed. It is created by eHealthMe based on reports of 11,196 people who have side effects when taking Sudafed from the FDA, and is updated regularly.

What is Sudafed?

Sudafed has active ingredients of pseudoephedrine hydrochloride. It is often used in nasal congestion. eHealthMe is studying from 12,944 Sudafed users. Check the latest studies of Sudafed.

What is Bronchiectasis?

Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection) is found to be associated with 784 drugs and 858 conditions by eHealthMe. Check the latest studies of Bronchiectasis.

On Jul, 20, 2026

11,196 people reported to have side effects when taking Sudafed.
Among them, 14 people (0.13%) have Bronchiectasis.

Among these 14 people:

How long have people been on Sudafed when they have Bronchiectasis? *

What is the gender of people who have Bronchiectasis when taking Sudafed? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Bronchiectasis when taking Sudafed? *

What are other drugs people take besides Sudafed? *

What are other side effects people have besides Bronchiectasis? *

Infection: 8 people, 57.14%
Fatigue (feeling of tiredness): 6 people, 42.86%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 5 people, 35.71%
Migraine (headache): 5 people, 35.71%
Headache (pain in head): 5 people, 35.71%
Infusion Site Pain: 4 people, 28.57%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 28.57%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 28.57%
Influenza Like Illness: 4 people, 28.57%
Hypersensitivity: 4 people, 28.57%

What are the existing conditions these people have? *

Immunodeficiency: 4 people, 28.57%
Primary Immunodeficiency Syndrome: 4 people, 28.57%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 21.43%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 21.43%
Anaemia (lack of blood): 3 people, 21.43%
Senile Osteoporosis (weak bones with ageing): 2 people, 14.29%
Polyneuropathy Alcoholic (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously due to alcohol): 2 people, 14.29%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Tachycardia Paroxysmal (a form of tachycardia which begins and ends in an acute (or paroxysmal) manner): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Sudafed and have Bronchiectasis?

- Check whether Bronchiectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sudafed:

Sudafed (12,944 reports)

Bronchiectasis treatments and more:

Bronchiectasis (12,460 reports)

Browse all side effects of Sudafed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchiectasis:

Bronchiectasis (784 drugs)

Browse all the conditions that are associated with Bronchiectasis:

Bronchiectasis (858 conditions)

Related publications that referenced our studies

Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .
Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on pseudoephedrine hydrochloride (the active ingredients of Sudafed) and Sudafed (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.